IDO1 and pachyonychia congenita: Furthermore, the expression levels of both IDO1 and TDO2 exhibit a negative correlation with patients’ survival time, indicating that the combined presence of IDO1 and TDO2, rather than either alone, serves as an independent prognostic indicator for PC.